Reported 2 days ago
Shares of Hims & Hers Health and LifeMD have surged significantly after Novo Nordisk announced plans to distribute its popular weight loss drug Wegovy through telehealth providers. Hims & Hers saw its stock jump 24%, while LifeMD increased by 34%. This partnership resolves previous supply shortages and enhances both companies' revenue potential, although concerns about high stock valuations remain, especially for Hims & Hers.
Source: YAHOO